• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Oncology
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • AI Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Licensing deals

Asia
Pharma

Boehringer-SBP, Fresenius-WuXi Bio, Evommune—Fierce Pharma Asia

BI formed a $7.4 billion tie-up with SBP. Fresenius collaborates with WuXi Bio in sweeping biosimilars deal. Evommune got a molecular glue from China.
Angus Liu Nov 6, 2026 8:04am
Asia

COINS Act, Hengrui, Samsung Biologics—Fierce Pharma Asia

Oct 23, 2026 8:42am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together
Favicon Fierce Biotech

Treasury COINS rules add biotech, spares China licensing deals

Oct 22, 2026 11:36pm
China flag against blue sky
Favicon Fierce Biotech

China looks to ban foreign acquisitions of key biotech platforms

Oct 16, 2026 10:38am
deal handshake business cooperation partnerships

Teva, Samsung Bioepis deepen biosimilar bonds with new deal

Oct 2, 2026 10:00am
Asia

AZ-Summit, Novo-Hengrui, Merck—Fierce Pharma Asia

Oct 2, 2026 9:35am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings